chitosan has been researched along with Metabolic Acidosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bari, F; Dékány, I; Farkas, E; Hantosi, D; Ivánkovits-Kiss, O; Janovák, L; Menyhárt, Á; Szabó, Í; Tóth, OM; Varga, DP; Varga, VÉ | 1 |
| Abdelghafour, MM; Bari, F; Bozó, É; Csapó, E; Deák, Á; Dékány, I; Farkas, E; Janovák, L; Juhász, Á; Mérai, L; Sebők, D; Turcsányi, Á | 1 |
2 other study(ies) available for chitosan and Metabolic Acidosis
| Article | Year |
|---|---|
Chitosan nanoparticles release nimodipine in response to tissue acidosis to attenuate spreading depolarization evoked during forebrain ischemia.
Topics: Acidosis; Animals; Biocompatible Materials; Brain Ischemia; Calcium Channel Blockers; Carotid Artery, Common; Cell Survival; Cerebrovascular Circulation; Chitosan; Cortical Spreading Depression; Drug Carriers; Drug Delivery Systems; Hydrogen-Ion Concentration; Microglia; Nanoparticles; Neurons; Nimodipine; Prosencephalon; Rats | 2020 |
Preparation of novel tissue acidosis-responsive chitosan drug nanoparticles: Characterization and in vitro release properties of Ca
Topics: Acidosis; Calcium Channel Blockers; Chitosan; Drug Carriers; Drug Liberation; Humans; Nanoparticles; Nimodipine | 2018 |